SGMO - Sangamo Therapeutics, Inc. Sotuvning sof marjinal rentabelligi

Sangamo Therapeutics, Inc. - SGMO emitenti grafik logotipi

Sangamo Therapeutics kamyob biomateriallar ta'minotini diversifikatsiya qilish orqali biznes barqarorligini ta'minlaydi. Muvozanatlashgan sof marja operatsion jarayonlarning samaradorligini ko'rsatadi, bunda -310.80 qiymati joriy ko'rsatkichni ifodalaydi. Daromadlar genetik patologiyalarni davolash bo'yicha sherikliklarga asoslangan; biroq, cheklangan naqd pul zaxiralari va klinik tadqiqotlar strategiyasining qayta ko'rib chiqilishi kompaniyaning barqarorligiga jiddiy xavflar tug'diradi.

Sangamo BioSciences (SGMO) Sof foyda marjasi: 04.07.2022 - 09.05.2026 davri uchun

SGMO (Sangamo Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- pul mavjudligi va pul oqimlari ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:Sangamo Therapeutics Inc. - SGMO
Sangamo BioSciences tayyor mahsulotlari

Konservativ investorlar daromadning har bir dollari uchun sof foyda marjasini kuzatishlari kerak, chunki asosiy sof savdo marjasi xarajatlarni boshqarish samaradorligini va yakuniy daromadlilikni ob'ektiv ravishda aks ettiradi. Sangamo Therapeutics (SGMO) uchun ushbu ko'rsatkich, gen terapiyasi sohasidagi texnologik ustunlik kompaniyaga premium narxlarni belgilash imkoniyatini yaratganidan va uzoq muddatli daromadlilik tendentsiyasini o'zgartirganidan so'ng, sink barmog'i patentlarining monetizatsiyasini tasdiqlovchi asosiy omil bo'lib xizmat qiladi.

Sangamo Therapeutics (SGMO) raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX